Case report highlights diagnostic value of 18F-OC PET/CT in phosphaturic mesenchymal tumor resulting in osteomalacia.
Phosphaturic mesenchymal tumor (PMT) is an uncommon neoplasm and the leading cause of tumor-induced osteomalacia (TIO). We report a 55-year-old woman with a 2-year history of progressive hip pain and hypophosphatemia. Laboratory findings demonstrated renal phosphate wasting. Conventional imaging revealed a small soft-tissue nodule in the right thigh, and 18F-AlF-NOTA-octreotide (18F-OC) PET/CT (positron emission tomography/computed tomography) showed intense radiotracer uptake, accurately localizing the culprit lesion. Surgical excision confirmed a PMT, and serum phosphate levels normalized postoperatively with resolution of symptoms. This case highlights the diagnostic value of 18F-OC PET/CT in detecting small PMTs and underscores the importance of considering TIO in patients with persistent hypophosphatemia and unexplained musculoskeletal symptoms.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: